Related Experiment Video
Updated: May 11, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Genetic instability of modified stem cells - a first step towards malignant transformation?
Doris Steinemann1, Gudrun Göhring, Brigitte Schlegelberger
1Institute of Cell and Molecular Pathology, Hannover Medical School Hannover, Germany.
American Journal of Stem Cells
|May 15, 2013
Summary
Induced pluripotent stem cells (iPSCs) are valuable for regenerative medicine but carry risks. Reprogramming methods can cause genetic instability, leading to altered iPSC populations that may impact research and therapies.
Area of Science:
- Stem Cell Biology
- Genetics
- Regenerative Medicine
Background:
- Induced pluripotent stem cells (iPSCs) are crucial for regenerative medicine.
- The reprogramming process for iPSCs, especially using oncogenes and long-term culture, may introduce genetic instability.
- Genetically altered iPSCs can outcompete normal cells in culture.
Purpose of the Study:
- To review current knowledge on genetic instability in embryonic stem cells and iPSCs.
- To focus on cytogenetic alterations in these cells.
- To compare iPSC genetic alterations with those observed in tumorigenesis.
Main Methods:
- Comprehensive literature review.
- Analysis of cytogenetic data from embryonic stem cells and iPSCs.
- Comparison with genetic changes in tumors.
Main Results:
- The reprogramming process can lead to significant genetic alterations in iPSCs.
- Cytogenetic abnormalities are frequently observed in both embryonic stem cells and iPSCs.
- There are parallels between genetic instability in iPSCs and tumorigenesis.
Conclusions:
- Genetic instability is a critical concern for the safe application of iPSCs in regenerative medicine.
- Understanding these alterations is essential for developing safer reprogramming protocols.
- Further research is needed to mitigate genetic risks associated with iPSC technology.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...